Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP878372.RAl-pMLufAStKy9QWo6GhF5CHosclao3ZXa6TzTBpZlKw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP878372.RAl-pMLufAStKy9QWo6GhF5CHosclao3ZXa6TzTBpZlKw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP878372.RAl-pMLufAStKy9QWo6GhF5CHosclao3ZXa6TzTBpZlKw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP878372.RAl-pMLufAStKy9QWo6GhF5CHosclao3ZXa6TzTBpZlKw130_provenance.
- befree-2016 importedOn "2016-02-19" NP878372.RAl-pMLufAStKy9QWo6GhF5CHosclao3ZXa6TzTBpZlKw130_provenance.
- NP878372.RAl-pMLufAStKy9QWo6GhF5CHosclao3ZXa6TzTBpZlKw130_assertion wasGeneratedBy ECO_0000203 NP878372.RAl-pMLufAStKy9QWo6GhF5CHosclao3ZXa6TzTBpZlKw130_provenance.
- NP878372.RAl-pMLufAStKy9QWo6GhF5CHosclao3ZXa6TzTBpZlKw130_assertion wasDerivedFrom befree-2016 NP878372.RAl-pMLufAStKy9QWo6GhF5CHosclao3ZXa6TzTBpZlKw130_provenance.
- NP878372.RAl-pMLufAStKy9QWo6GhF5CHosclao3ZXa6TzTBpZlKw130_assertion SIO_000772 21389325 NP878372.RAl-pMLufAStKy9QWo6GhF5CHosclao3ZXa6TzTBpZlKw130_provenance.
- NP878372.RAl-pMLufAStKy9QWo6GhF5CHosclao3ZXa6TzTBpZlKw130_assertion evidence source_evidence_literature NP878372.RAl-pMLufAStKy9QWo6GhF5CHosclao3ZXa6TzTBpZlKw130_provenance.
- NP878372.RAl-pMLufAStKy9QWo6GhF5CHosclao3ZXa6TzTBpZlKw130_assertion description "[Although IFNα at present remains an experimental form of therapy for patients with myeloid malignancies, these promising results suggest that it may become again an important component of the therapeutic arsenal for this group of hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878372.RAl-pMLufAStKy9QWo6GhF5CHosclao3ZXa6TzTBpZlKw130_provenance.